FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition that comprises the following components, %: hydrophobic active component representing cyclosporine and/or taxane, 0.1-30.0; one or some gelatinizing substances chosen from fatty acid polyglycerol esters, 0.1-60.0; one or some gel-forming substances chosen from fatty acid polyglycerol esters and/or unsaturated fatty acids, 0.1-60.0; one or some substances chosen from triglyceride macrogol glycerol esters, partial glycerides or fatty acids, or fatty acid macrogol esters, 1.0-60.0, and ethanol, 5.0-30.0. In dilution with water the composition forms dispersion of polymorphous nonspherical gel particles having size from 0.2 to 500 mcm. Invention provides acceptable bioavailability of therapeutically active cyclosporines and taxanes showing difficult solubility in water.
EFFECT: improved and valuable properties of pharmaceutical compositions.
13 cl, 8 dwg, 1 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR ORAL OR TOPICAL USING | 2000 |
|
RU2279894C2 |
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING COMPOUND HAVING HYDROGEN-LINKING ABILITY, AND METHOD OF COSMETIC TREATMENT | 2009 |
|
RU2432151C2 |
USE OF POLYGLYCEROL ESTERS AS TRIBO-MODIFIERS IN LUBRICATING COMPOSITIONS | 2016 |
|
RU2726194C2 |
PEROXIDE DISPERSIONS | 2013 |
|
RU2631815C2 |
PEROXIDE DISPERSIONS | 2013 |
|
RU2663168C1 |
ORAL PHARMACEUTICAL COMPOSITIONS BASED ON PRODUCTS CONTAINING LIPASES, FIRST OF ALL PANCREATINE, AND SURFACTANTS | 2005 |
|
RU2381813C2 |
PEROXIDE DISPERSIONS | 2014 |
|
RU2650394C2 |
CLEARING SUSPENDING CLEANING COMPOSITIONS FOR PERSONAL HYGIENE | 2017 |
|
RU2742036C2 |
PRELIMINARY PREPARED EMULSION CONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDE | 1999 |
|
RU2235554C2 |
Authors
Dates
2006-07-20—Published
2003-11-17—Filed